306 related articles for article (PubMed ID: 25879139)
1. Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.
Chen G; Gorelik L; Simon KJ; Pavlenco A; Cheung A; Brickelmaier M; Chen LL; Jin P; Weinreb PH; Sidhu SS
MAbs; 2015; 7(4):681-92. PubMed ID: 25879139
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity.
Gorelik L; Reid C; Testa M; Brickelmaier M; Bossolasco S; Pazzi A; Bestetti A; Carmillo P; Wilson E; McAuliffe M; Tonkin C; Carulli JP; Lugovskoy A; Lazzarin A; Sunyaev S; Simon K; Cinque P
J Infect Dis; 2011 Jul; 204(1):103-14. PubMed ID: 21628664
[TBL] [Abstract][Full Text] [Related]
4. JCPyV VP1 Mutations in Progressive MultifocalLeukoencephalopathy: Altering Tropismor Mediating Immune Evasion?
Lauver MD; Lukacher AE
Viruses; 2020 Oct; 12(10):. PubMed ID: 33053912
[TBL] [Abstract][Full Text] [Related]
5. Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML).
Sunyaev SR; Lugovskoy A; Simon K; Gorelik L
PLoS Genet; 2009 Feb; 5(2):e1000368. PubMed ID: 19197354
[TBL] [Abstract][Full Text] [Related]
6. Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: a diagnostic tool for progressive multifocal leukoencephalopathy.
Aoki N; Mori M; Kato K; Sakamoto Y; Noda K; Tajima M; Shimada H
Neurosci Lett; 1996 Feb; 205(2):111-4. PubMed ID: 8907329
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of human polyomavirus JC in Brazilian AIDS patients with and without progressive multifocal leukoencephalopathy.
Fink MC; de Oliveira AC; Romano CM; Vidal JE; Urbano PR; Tateno AF; Oliveira CM; de Albuquerque Luna EJ; Pannuti CS
J Clin Virol; 2010 May; 48(1):6-10. PubMed ID: 20335066
[TBL] [Abstract][Full Text] [Related]
8. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
9. JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy.
Delbue S; Branchetti E; Bertolacci S; Tavazzi E; Marchioni E; Maserati R; Minnucci G; Tremolada S; Vago G; Ferrante P
J Neurovirol; 2009 Jan; 15(1):51-6. PubMed ID: 19043822
[TBL] [Abstract][Full Text] [Related]
10. [Progress on pathogenesis of progressive multifocal leukoence-phalopathy].
Hu C; Zhu B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):534-540. PubMed ID: 30693697
[TBL] [Abstract][Full Text] [Related]
11. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.
Tan CS; Ghofrani J; Geiger E; Koralnik IJ; Jost S
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):220-224. PubMed ID: 31513076
[TBL] [Abstract][Full Text] [Related]
12. JC polyomavirus mutants escape antibody-mediated neutralization.
Ray U; Cinque P; Gerevini S; Longo V; Lazzarin A; Schippling S; Martin R; Buck CB; Pastrana DV
Sci Transl Med; 2015 Sep; 7(306):306ra151. PubMed ID: 26400912
[TBL] [Abstract][Full Text] [Related]
13. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.
Koralnik IJ; Du Pasquier RA; Kuroda MJ; Schmitz JE; Dang X; Zheng Y; Lifton M; Letvin NL
J Immunol; 2002 Jan; 168(1):499-504. PubMed ID: 11751998
[TBL] [Abstract][Full Text] [Related]
14. Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.
Geoghegan EM; Pastrana DV; Schowalter RM; Ray U; Gao W; Ho M; Pauly GT; Sigano DM; Kaynor C; Cahir-McFarland E; Combaluzier B; Grimm J; Buck CB
Cell Rep; 2017 Oct; 21(5):1169-1179. PubMed ID: 29091757
[TBL] [Abstract][Full Text] [Related]
15. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Schmitz JE; Zheng Y; Martin K; Peyerl FW; Lifton M; Gorgone D; Autissier P; Letvin NL; Koralnik IJ
J Virol; 2003 Nov; 77(22):11918-26. PubMed ID: 14581528
[TBL] [Abstract][Full Text] [Related]
16. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
[TBL] [Abstract][Full Text] [Related]
17. New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy.
Zheng HY; Takasaka T; Noda K; Kanazawa A; Mori H; Kabuki T; Joh K; Oh-Ishi T; Ikegaya H; Nagashima K; Hall WW; Kitamura T; Yogo Y
J Gen Virol; 2005 Jul; 86(Pt 7):2035-2045. PubMed ID: 15958683
[TBL] [Abstract][Full Text] [Related]
18. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.
Koralnik IJ
J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153
[TBL] [Abstract][Full Text] [Related]
19. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
Koralnik IJ; Du Pasquier RA; Letvin NL
J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
[TBL] [Abstract][Full Text] [Related]
20. Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response.
Frye S; Trebst C; Dittmer U; Petry H; Bodemer M; Hunsmann G; Weber T; Lüke W
J Virol Methods; 1997 Jan; 63(1-2):81-92. PubMed ID: 9015278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
